Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Revenues $ 0 $ 0 $ 0 $ 0
Costs and Expenses        
Operating expenses 493,000 431,000 1,626,000 1,387,000
Research and development expenses 82,000 50,000 665,000 145,000
Loss before other expense (575,000) (481,000) (2,291,000) (1,532,000)
Other expense        
Interest and financing expense (413,000) (200,000) (2,437,000) (607,000)
Net loss $ (988,000) $ (681,000) $ (4,728,000) $ (2,139,000)
Net loss per common share, basic and diluted $ (0.00) $ (0.00) $ (0.02) $ (0.01)
Weighted average common shares outstanding, basic and diluted 298,834,404 251,732,417 286,120,559 243,167,707